The Role of BEMER and Kinesiotape in Increasing the Effectiveness of Physiotherapy and Rehabilitation Program After Videothoracoscopy Surgery

December 6, 2022 updated by: MAKBULE KARCI, Istanbul University - Cerrahpasa (IUC)

The Role of BEMER and Kinesiotape in Increasing the Effectiveness of Physiotherapy and

The literature indicates that postoperative pulmonary complications are seen when pain is not treated effectively after videothoracoscopy surgery (VATS). After surgery, physiotherapy and rehabilitation approaches are applied to prevent complications. Bio-Electro-Magnetic-Energy-Regulation (BEMER) therapy uses low-frequency electromagnetic energy to regulate vasomotion in capillaries and increase microcirculation. BEMER therapy can be applied together with physiotherapy and rehabilitation. The aim of this study is to investigate the effectiveness of BEMER application, which is added to the physiotherapy and rehabilitation program applied after videothoracoscopy surgery.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İ̇stanbul, Turkey, 34540
        • Istanbul University - Cerrahpasa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 71 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Inclusion criteria for the study were to have undergone VATS lobectomy and to be aged between 18 and 75 years.

Exclusion Criteria:

  • Presence of pacemaker, severe cardiac failure, severe arrhythmia
  • Those with cooperative disorders
  • Presence of neurological or orthopedic problems affecting the extremities
  • Those with severe psychiatric disorders
  • Failure to perform the operation according to the result of intraoperative tumor staging
  • Patients who go out of the standard Analgesia protocol
  • Patients who were taken back from the service to the intensive care unit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BEMER Group
BEMER application with routine treatment protocol
Other: BEMER Group
BEMER therapy and Physiotherapy and Rehabilitation Program After Videothoracoscopy Surgery
Experimental: Kinesiotape Group
Kinesiotape application with routine treatment protocol
Other: Kinesiotape Group
Kinesiotape application and Physiotherapy and Rehabilitation Program After Videothoracoscopy Surgery
Experimental: Control Group
routine treatment protocol
Other: Control Group
Physiotherapy and Rehabilitation Program After Videothoracoscopy Surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Baseline in Pain Scores
Time Frame: Postoperative 4th day
Change From Baseline in Pain Scores on the Visual Analog Scale at Postoperative 4th day
Postoperative 4th day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istanbul University - Cerrahpasa (IUC)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

February 1, 2021

Study Completion (Anticipated)

December 20, 2022

Study Registration Dates

First Submitted

November 11, 2022

First Submitted That Met QC Criteria

December 6, 2022

First Posted (Estimate)

December 14, 2022

Study Record Updates

Last Update Posted (Estimate)

December 14, 2022

Last Update Submitted That Met QC Criteria

December 6, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ICU-KARCI-3477

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe